Skip to main content
Premium Trial:

Request an Annual Quote

Does Uncle Sam Want Your Bioinformatics Tools? DoD Funding Opportunities Abound

Premium

NIH and NSF aren’t the only sources of bioinformatics funding in the US. A number of bioinformatics organizations are already benefiting from the DoD’s ever-growing budget. Consulting firm 3rd Millennium, for example, received a Phase I SBIR contract from the USA-MRMC in Feb. 2002 to develop a bioinformatics system to manage and analyze microarray data. In addition, the Virginia Bioinformatics Institute received a $4.5 million appropriation from Congress in Jan. 2002 for bioinformatics resources and research “with a particular focus on the study of biological threats.” Additionally, the Buffalo Center of Excellence in Bioinformatics received $2 million in DoD appropriations last July.

The Department of Defense Appropriations Act of 2003 provides a total of $355.1 billion in new funding for the DoD, of which $14.8 billion is earmarked for the Defense Health Program, and $459 million of that is set aside for R&D. In addition, the DoD’s Chemical and Biological Defense Initiatives Fund provides $25 million for a range of research areas, including bioinformatics.

Think your project may be of interest to the US military? Here’s a selection of DoD websites with information on submitting unsolicited proposals:

In addition, there are several open SBIR grants available through the DoD:

Accelerated Drug Design Through Computational Biology. Agency: Medical Research and Materiel Command. Closes: August 14, 2003.

Seeking projects to develop computational models for lead compound identification, specifically considering candidate proteins from the malaria parasite Plasmodium falciparum. Phase I will support development of computational methodologies to generate molecular models of various target proteins. Phase II will support use of the system validated in Phase I to generate molecular models of additional target proteins.

 

Biological Effects Pattern Recognition Tool Using Multivariate Statistical Data Reduction. Agency: Defense Health Biomedical/Information Management Technology. Closes: August 14, 2003.

Seeking a project to develop a multivariate statistical analysis software tool for measuring and interpreting complex, time-related, global changes in gene, protein, and metabolite expression pattern profiles that will identify toxic substances exposure at subtoxic concentrations. Phase I will support development of a prototype software tool to reduce the complexity of multi-dimensional data with a focus on evaluating the toxicological hazards associated with low-level chemical exposures. Phase II will validate the prototype.

Filed under

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.